Novartis Will Bundle Coronado's PNT Glaucoma Device With Rescula Drops
This article was originally published in The Gray Sheet
Executive Summary
Novartis Ophthalmics' exclusive licensing and distribution agreement with Coronado Industries will allow the company to offer ophthalmologists Coronado's PNT (pneumatic trabeculoplasty) suction device for primary treatment of glaucoma along with its own Rescula glaucoma drops.